Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

805.02
-14.0700-1.72%
Post-market: 804.00-1.0200-0.13%19:30 EDT
Volume:527.74K
Turnover:425.48M
Market Cap:82.88B
PE:19.91
High:819.09
Open:819.09
Low:801.22
Close:819.09
52wk High:859.34
52wk Low:575.93
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.82
T/O Rate:0.53%
Dividend:3.64
Dividend Rate:0.45%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.61
PE(LYR):19.41

Loading ...

Oct 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2026

Major Issues Report

Form 8-K - Current report
Sep 30, 2026

Major Issues Report

Form 8-K - Current report
Sep 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2026

Major Issues Report

Form 8-K - Current report
Apr 08, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities